4th Quarter - Report

SOLVENTUM CORPORATION for SOLVENTUM CORPORATION

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

-Issues related to Department of Defense policy, procurement, and contracting processes for medical technology.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

-Issues related to domestic and global medical supply chain resiliency.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

-Issues related to Veterans Administration and Veterans Health Administration policy, procurement, and contracting processes for medical technology.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —

Contacted: SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Health Issues HCR

-Issues related to regulation of Ethylene Oxide (EtO). -Issues related to access to sterilization capacity for medical technologies. -Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —

Contacted: Environmental Protection Agency (EPA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

-Medicare and Medicaid payment quality programs and policies, including healthcare associated complications, readmissions, payment bundling, potentially avoidable events, quality outcomes, transparency, telehealth, health equity, social determinants of health, maternal mortality, risk adjustment, Medicare Advantage, value-based payment policies, and Medicare and Medicaid data. -VA provider coding system modernization. -Implementation of the Patient Protection and Affordable Care Act (PL 111-148). -Implementation of the Helping Hospitals Improve Patient Care Act 21st Century Cures Act (PL 114-255). -Regulations and legislation related to International Classification of Diseases, version 10 (ICD-10). -Healthcare Outcomes Act. -Issues related to the use of Artificial Intelligence.

LobbyistCovered position, as disclosed
JENNIFER NIETO CAREY —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.